FindTrial
Sign In

A study on efficacy of fractional CO2 LASER with topical Latanoprost vs fractional CO2 LASER with topical Tofacitinib in stable vitiligo - An interventional study

A study on efficacy of fractional CO2 LASER with topical Latanoprost vs fractional CO2 LASER with topical Tofacitinib in stable vitiligo - An interventional study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068808
Enrollment
58
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Fractional CO2 LASER with topical Tofacitinib: For 8 weeks with interval of 2 weeks and daily topical Tofacitinib application for 8 weeks Intervention2: Fractional CO2 LASER with topic

Sponsors

Bommaka Sruthi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients above 6 years of age

Exclusion criteria

Exclusion criteria: Patients with keloidal tendency Pregnant or lactating women Patients with vitiligo associated syndromes Patients who are not willing to participate in study

Design outcomes

Primary

MeasureTime frame
Repigmentation will be assessed using dermoscopy and photographic assessment using MIISP score and GPA scoreTimepoint: Baseline, 4weeks, 8weeks.—

Secondary

MeasureTime frame
Adverse effects of fractional CO2 LASER, Tofacitinib, Latanoprost.Timepoint: Before each sitting -every 2 weeks and At end point of 4 sessions and 2 weeks after last session—

Countries

India

Contacts

Public ContactDr Sruthi

Sri Devaraj Urs Medical College

sk5787@gmail.com9535071967

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026